Loperamide Abuse Triggers Look At Potential Label Warning
This article was originally published in The Tan Sheet
Executive Summary
Monitoring of AERs prompts concern about the ingredient used in OTC anti-diarrheal products, CDER says a day after it noted adverse event reports in announcing concerns about a risk of serious bleeding linked to use of OTC antacid/aspirin products.